# \[e-drug\] Bio-Equivalence (cont)

**URL:** <https://talk.edrugplus.org/t/e-drug-bio-equivalence-cont/15690>\
**Category:** e-drug\
**Created:** [December 14, 2002, 5:03am UTC](https://talk.edrugplus.org/t/e-drug-bio-equivalence-cont/15690 "2002-12-14T05:03:34Z")\
**Posts on this page:** 1\
**Page:** 1

<div class="post-metadata">

**Author:** ![joel.lexchin](https://avatars.discourse-cdn.com/v4/letter/j/e9c0ed/32.png) [@joel.lexchin](https://talk.edrugplus.org/u/joel.lexchin)\
**Post date:** [December 14, 2002, 5:03am UTC](https://talk.edrugplus.org/t/e-drug-bio-equivalence-cont/15690/1 "2002-12-14T05:03:34Z")

</div>

E-drug: Bio-Equivalence (cont)  
---------------------------------------------

Before any generic is approved in Canada it must be shown to be bioequivalent  
to the original product. For more information about Canadian bioequivalence  
requirements go to the following web site  
\<[http://www.hc-sc.gc.ca/hpb-dgps/therapeut/htmleng/guidmain.html#bioavail&gt;\](http://www.hc-sc.gc.ca/hpb-dgps/therapeut/htmleng/guidmain.html#bioavail&gt;%5C).

[repair URL]  
Joel Lexchin  
121 Walmer Rd.  
Toronto, Canada  
Tel: 416-964-7186  
Fax: 416-923-9515  
e mail: joel.lexchin@utoronto.ca

--  
To send a message to E-Drug, write to: e-drug@usa.healthnet.org  
To subscribe or unsubscribe, write to: majordomo@usa.healthnet.org  
in the body of the message type: subscribe e-drug OR unsubscribe e-drug  
To contact a person, send a message to: e-drug-help@usa.healthnet.org  
Information and archives: [http://www.essentialdrugs.org/edrug](http://www.essentialdrugs.org/edrug)